374 related articles for article (PubMed ID: 16396764)
1. Prognostic significance of monocytosis in patients with myeloproliferative disorders.
Beran M; Shen Y; Onida F; Wen S; Kantarjian H; Estey E
Leuk Lymphoma; 2006 Mar; 47(3):417-23. PubMed ID: 16396764
[TBL] [Abstract][Full Text] [Related]
2. Philadelphia-negative (Ph-) chronic myeloid leukemia (CML): comparison with Ph+ CML and chronic myelomonocytic leukemia. The Groupe Français de Cytogénétique Hématologique.
Martiat P; Michaux JL; Rodhain J
Blood; 1991 Jul; 78(1):205-11. PubMed ID: 2070054
[TBL] [Abstract][Full Text] [Related]
3. Cytopenia, dysplasia, and monocytosis: a precursor to chronic myelomonocytic leukemia or a distinct subgroup? Case reports and review of literature.
Singh ZN; Post GR; Kiwan E; Maddox AM
Clin Lymphoma Myeloma Leuk; 2011 Jun; 11(3):293-7. PubMed ID: 21658659
[TBL] [Abstract][Full Text] [Related]
4. Significance and correlations of molecular analysis results in patients with Philadelphia chromosome-negative chronic myelogenous leukemia and chronic myelomonocytic leukemia.
Kantarjian HM; Shtalrid M; Kurzrock R; Blick M; Dalton WT; LeMaistre A; Stass SA; McCredie KB; Gutterman J; Freireich EJ
Am J Med; 1988 Nov; 85(5):639-44. PubMed ID: 3189367
[TBL] [Abstract][Full Text] [Related]
5. Chronic myelomonocytic leukaemia (CMML)--a myelodysplastic or myeloproliferative syndrome?
Michaux JL; Martiat P
Leuk Lymphoma; 1993 Jan; 9(1-2):35-41. PubMed ID: 8477199
[TBL] [Abstract][Full Text] [Related]
6. The relationship between the myelodysplastic syndromes and the myeloproliferative disorders.
Bain BJ
Leuk Lymphoma; 1999 Aug; 34(5-6):443-9. PubMed ID: 10492067
[TBL] [Abstract][Full Text] [Related]
7. Haematological classification of the chronic myeloid leukaemias.
Shepherd PC; Ganesan TS; Galton DA
Baillieres Clin Haematol; 1987 Dec; 1(4):887-906. PubMed ID: 3332855
[TBL] [Abstract][Full Text] [Related]
8. Characteristics and outcome of patients with Philadelphia chromosome negative, bcr/abl negative chronic myelogenous leukemia.
Onida F; Ball G; Kantarjian HM; Smith TL; Glassman A; Albitar M; Scappini B; Rios MB; Keating MJ; Beran M
Cancer; 2002 Oct; 95(8):1673-84. PubMed ID: 12365015
[TBL] [Abstract][Full Text] [Related]
9. [Detection of BCR/ABL fusion gene by fluorescence in situ hybridization and its clinical application].
Zhou RL; Mo YX; Lan M; Lin JY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Oct; 19(5):1283-8. PubMed ID: 22040989
[TBL] [Abstract][Full Text] [Related]
10. Philadelphia chromosome-negative chronic myelogenous leukemia with rearrangement of the breakpoint cluster region. Long-term follow-up results.
Cortes JE; Talpaz M; Beran M; O'Brien SM; Rios MB; Stass S; Kantarjian HM
Cancer; 1995 Jan; 75(2):464-70. PubMed ID: 7812917
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors in myelodysplastic and myeloproliferative types of chronic myelomonocytic leukemia: a retrospective analysis of 83 patients from a single institution.
Breccia M; Latagliata R; Mengarelli A; Biondo F; Mandelli F; Alimena G
Haematologica; 2004 Jul; 89(7):866-8. PubMed ID: 15257942
[TBL] [Abstract][Full Text] [Related]
12. Chronic myeloid leukemia with p210 BCR-ABL and monocytosis.
Dass J; Jain S; Tyagi S; Sazawal S
Leuk Lymphoma; 2011 Jul; 52(7):1380-1. PubMed ID: 21425959
[No Abstract] [Full Text] [Related]
13. P190BCR-ABL chronic myeloid leukaemia: the missing link with chronic myelomonocytic leukaemia?
Melo JV; Myint H; Galton DA; Goldman JM
Leukemia; 1994 Jan; 8(1):208-11. PubMed ID: 8289491
[TBL] [Abstract][Full Text] [Related]
14. Hematopoietic progenitor cell colony growth differentiates chronic myelomonocytic leukemia from reactive monocytosis.
Birrer A; Jusufi F; Bernimoulin M; Tichelli A; Gratwohl A; Nissen-Druey C; Dirnhofer S; Meyer-Monard S; Stern M
Eur J Haematol; 2008 Oct; 81(4):267-72. PubMed ID: 18616511
[TBL] [Abstract][Full Text] [Related]
15. [Differential diagnosis of chronic myeloid leukemia and the related disorders].
Ashida T; Kanamaru A
Nihon Rinsho; 2001 Dec; 59(12):2358-62. PubMed ID: 11766339
[TBL] [Abstract][Full Text] [Related]
16. Immunophenotype in chronic myelomonocytic leukemia: is it closer to myelodysplastic syndromes or to myeloproliferative disorders?
Subirá D; Font P; Villalón L; Serrano C; Askari E; Góngora E; Castañón S; Gonzalo R; Mata R; Román A; Llamas P
Transl Res; 2008 May; 151(5):240-5. PubMed ID: 18433705
[TBL] [Abstract][Full Text] [Related]
17. Chronic myelomonocytic leukemia monocytes uniformly display a population of monocytes with CD11c underexpression.
Sojitra P; Gandhi P; Fitting P; Kini AR; Alkan S; Velankar MM; Venkataraman G
Am J Clin Pathol; 2013 Nov; 140(5):686-92. PubMed ID: 24124148
[TBL] [Abstract][Full Text] [Related]
18. Monocyte subset distribution in myeloproliferative and myelodysplastic/myeloproliferative neoplasms with monocytosis.
Sorigue M; Arenillas L; Xicoy B; Andrade-Campos M; Navarro JT; Ferrer A; Zamora L; Calvo X
Leuk Res; 2022 Jan; 112():106771. PubMed ID: 34902713
[No Abstract] [Full Text] [Related]
19. RAS mutations contribute to evolution of chronic myelomonocytic leukemia to the proliferative variant.
Ricci C; Fermo E; Corti S; Molteni M; Faricciotti A; Cortelezzi A; Lambertenghi Deliliers G; Beran M; Onida F
Clin Cancer Res; 2010 Apr; 16(8):2246-56. PubMed ID: 20371679
[TBL] [Abstract][Full Text] [Related]
20. A case of atypical chronic myeloid leukemia regarded as MDS with myeloproliferative features.
Tohda S; Koyama N; Tanaka M; Kida Y; Murakami N; Nara N
Acta Haematol; 1998; 100(4):191-4. PubMed ID: 9973641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
